. Targeting phospho-Ser422 by active Tau immunotherapy in the THY-Tau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res. 2012 Jan 23; PubMed.

Recommends

Please login to recommend the paper.

Comments

Comments on this Paper

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Truncated Tau Triggers Tangles, Transmits Pathology
  2. Antibodies Stop Toxic Tau in Its Extracellular Tracks

Therapeutics

  1. RG7345